Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100053302Phase 4Recruiting
Phase 4 trial of esketamine in bronchopulmonary diseases (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Hemodynamic changes, Induction quality and 1 more. Started Nov 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100053302.